Travere Therapeutics Inc. TVTX
$53.48
▲ +6.40% 24H
About
Travere Therapeutics Inc. is a biopharmaceutical company dedicated to the development and commercialization of pioneering therapies for rare diseases. The company's primary mission is to address unmet medical needs in patient populations that have few existing treatment options. Travere Therapeutics operates in the pha…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees497
TickerTVTX
Statistics
Market Cap$4.94B
Revenue (TTM)$490.7M
Net Income-$25.5M
Net Margin-5.2%
EPS$-0.29
P/E-179.48
P/S9.03
P/B48.73
EV/EBITDA304.72
ROE-69.4%
Dividend Yield—
Price$53.48
Data: Twelve Data · Revenue = mcap / P/S